The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 23 September, 2020, 02:47 PM IST | E-Paper
Search
+

    Anuj Gupta

    Lead - Healthcare, ET Prime

    A dental surgeon by training, I have worn many hats including that of a business consultant and now a journalist. At ET Prime, I will write on disruptors in healthcare and life sciences. Earlier, I w ...

    Read More

    Articles by the author

    Cannabis can solve agri crisis and fuel investments. But India is not yet ready to join the party.A tech shot in the arm: Backed by investors, THB and KnowYourMeds are tapping AI to empower patientsPrice cap on US stents may stay to keep healthcare affordable. But can India fill the research gap?New healthcare paradigm: Investors pick hospitals unlocking value through cost, capital efficiencies
    Healthcare stocks are in the dumps. But Dr Lal is still earning for everyone.National Medical Commission: a new pain in the making, or what the doctor ordered?Healthcare puzzle: Is the Modi government promoting Ayushman Bharat at the cost of primary care?Delhi High Court wants cashless claims in every hospital. Here’s why insurers are fearing the worst.
    When will India stop beating up doctors, its most critical human resource?Ab Dilli door nahi: Ranjan Pai is paying a hefty price for Medanta to break his northern jinxBuy them young, build them strong: TPG’s AHH has a magic pill to turn around healthcare businessesMax Bupa’s big question: If staying fit gets you 10% off on health insurance, will you buy?
    Health expenditure is a problem for Indians. AffordPlan and LetsMD are using tech to solve it.Will Metropolis Healthcare break India’s long IPO drought?Skewed national priorities: Motor insurance is mandatory, health cover isn’t. Here’s how we got here.USD2.5 million vs. USD42,325: Huge gap in J&J hip-implant compensations in the US and India proves the need for urgent reforms
    Political rivalry shouldn't scuttle Ayushman Bharat. The biggest losers will be the deserving patients.If insurers, policymakers, and IRDAI sort out teething issues, Indians can soon get an all-inclusive dental coverJana Care is turning your smartphone into a weapon against diabetesINR15,000 crore question: why primary wellness-centre entrepreneurs hold the key to Ayushman Bharat
    Yes, we cannabis: Medical marijuana is lighting up a USD100 billion opportunity. India’s turn to roll.Jawa, the old horse, is back in the race. But nostalgia alone won’t take it to the finish line before Royal Enfield.StayHappi, a pharmacy startup that sells only generics, wants to shrink your medicine bill. But will you let it?Ela Woman’s fertile business plan: how the Delhi-based startup’s algorithms are spreading cheer among childless couples and hit-seeking investors
    Hip hip hurray: homegrown cell therapy Ossgrow is quietly changing the lives of hip-replacement patientsThe many challenges ahead of Ayushman BharatBlame J&J, but the bigger culprits are DCGI and Indian lawsThe government wants to make medical devices affordable. But capping trade margins alone isn't a cure.
    The J&J hip-implant mess needs a closer lookIndia's half-baked medical-device regulation won't reduce patients' sufferings or rein in errant firmsHow policies choked small pharmaSankyo-Daiichi's move to block Fortis's sale surprised us: Fortis chairman Ravi Rajagopal
    Can the Fortis-IHH deal overcome "surprise" Daiichi roadblock?Making medical devices locally needs more than a diktat to succeedAyushman Bharat: India's miracle pill for all has a bitter coatingWhy capping prices of medical devices won't help India’s ailing
    The knights of IHH

    Leadership

    The knights of IHH
    9 mins read10 Jul 2018
    Why the queue of suitors for Fortis is thinningFormer board gets pass marks in Fortis's self-examinationSuperbugs have designs on India. Our preparation is inadequate.
    India's drug-pricing authority appears headed for its expiry dateThe humans of Fortis

    Hospitals

    The humans of Fortis
    9 mins read8 Jun 2018
    South Asian funds are seeking more appointments than ever with Indian hospitalsIndia wants to end TB by 2025. It can't.
    The Fortis board: directors or directed?Stem cells: minimum manipulation, maximum confusionFortis race to conclude today; IHH may take leadThe bid for Fortis may get hostile
    The bid for Fortis may get hostile
    03 May 2018 09:46 PM IST
    The difficulty of being RK VatsNo decision today on Fortis bids
    No decision today on Fortis bids
    26 Apr 2018 01:54 PM IST
    We rummaged through some Fortis files. What we found isn’t pretty.KKR-backed Radiant Life Care to make binding bid for Fortis tomorrow
    Race for Fortis: IHH may file binding offer before April 25Is Fortis going the Satyam way?
    Is Fortis going the Satyam way?
    19 Apr 2018 10:00 AM IST
    KKR-backed hospital chain Radiant Lifecare readies bid for FortisThe tightrope walk of India's drug-price regulator
    Stent prices under the cosh again, but who will bell the real cat?The tightrope walk of India's drug-price regulatorStent prices under the cosh again, but who will bell the real cat?Dr Lal PathLabs: Sweet pill in Dec quarter, expansion key to future growth
    Price cap on cardiac stents stifling innovation, harming patients: ManufacturersHow the Rs 3, 500 crore damages against Singh Brothers was arrived atHealth insurance cover for 10 crore, but the numbers do not add upFirst step in the long journey towards universal healthcare
    Twin boost for Modi’s reforms: What it means for pharma?
    The Economic Times